Statistics

Total Visits

Views
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models(legacy) 132
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models(legacy) 107

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models 2 13 1 3 0 9 1

File Downloads

Views
hdl_100143.pdf(legacy) 94
hdl_100143.pdf 82

Top Country Views

Views
United States 102
Australia 50
China 26
France 17
Netherlands 8
Vietnam 8
Spain 3
United Kingdom 3
Germany 2
Brazil 1

Top City Views

Views
Kaleen 31
Ashburn 19
Fairfield 17
Hanoi 8
Rotterdam 8
Des Moines 6
Adelaide 5
Buffalo 5
San Ramon 5
Boardman 4